Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing.
Renganthan SenthilSubrata PramanikRajasekaran EkambaramArne KutznerPok-Son KimKlaus HeesePublished in: Cancers (2021)
Family with sequence similarity 72 A (FAM72A) is a pivotal mitosis-promoting factor that is highly expressed in various types of cancer. FAM72A interacts with the uracil-DNA glycosylase UNG2 to prevent mutagenesis by eliminating uracil from DNA molecules through cleaving the N-glycosylic bond and initiating the base excision repair pathway, thus maintaining genome integrity. In the present study, we determined a specific FAM72A-UNG2 heterodimer protein interaction using molecular docking and dynamics. In addition, through in silico screening, we identified withaferin B as a molecule that can specifically prevent the FAM72A-UNG2 interaction by blocking its cell signaling pathways. Our results provide an excellent basis for possible therapeutic approaches in the clinical treatment of cancer.
Keyphrases
- molecular docking
- crispr cas
- genome editing
- papillary thyroid
- squamous cell
- circulating tumor
- molecular dynamics simulations
- signaling pathway
- single molecule
- cell free
- binding protein
- single cell
- lymph node metastasis
- squamous cell carcinoma
- cell therapy
- childhood cancer
- dna damage
- human health
- pi k akt
- endoplasmic reticulum stress